Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | PTPRC | P08575 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29383770 | 0.97 | PDK2 (0.46) | PDK2CYP2A6ALDH1A1PTPRCCASP1 | |
| SCHEMBL13828827 | 0.97 | PDK2 (0.46) | PDK2CYP2A6ALDH1A1PTPRCCASP1 | |
| SCHEMBL29562304 | 0.97 | PDK2 (0.46) | PDK2CYP2A6ALDH1A1PTPRCCASP1 | |
| SCHEMBL4243301 | 0.92 | KDM4E (0.41) | PDK2CYP2A6ALDH1A1MEN1MAPT | |
| SCHEMBL2790308 | 0.92 | KDM4E (0.41) | PDK2CYP2A6ALDH1A1MEN1MAPT | |
| SCHEMBL19197207 | 0.90 | CYP2A6 (0.55) | PDK2CYP2A6ALDH1A1PTPRCCYP3A4 | |
| SCHEMBL16683880 | 0.90 | KDM4E (0.42) | PDK2CYP2A6ALDH1A1MEN1MAPT | |
| SCHEMBL2606599 | 0.88 | KDM4E (0.41) | PDK2CYP2A6ALDH1A1MEN1MAPT | |
| SCHEMBL2793382 | 0.87 | CYP2A6 (0.44) | PDK2CYP2A6ALDH1A1PTPRCCYP3A4 | |
| SCHEMBL29420141 | 0.86 | CYP2A6 (0.45) | PDK2CYP2A6ALDH1A1PTPRCCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024176065-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, DISPLAY DEVICE, AND ELECTRONIC EQUIPMENT | 株式会社半導体エネルギー研究所 | 2024-08-29 | — | — | WO | disclosed |
| US-9115112-B2 | Aminoanthracene derivative and an organic electroluminescent element employing the same | DOOSAN CORPORATION (KR) | 2015-08-25 | — | — | US | disclosed |
| US-9115112-B2 | Aminoanthracene derivative and an organic electroluminescent element employing the same | DOOSAN CORPORATION (KR) | 2015-08-25 | — | — | US | disclosed |
| US-9115112-B2 | Aminoanthracene derivative and an organic electroluminescent element employing the same | DOOSAN CORPORATION (KR) | 2015-08-25 | — | — | US | disclosed |
| US-20120161615-A1 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | DOOSAN CORPORATION (KR) | 2012-06-28 | — | — | US | disclosed |
| US-20120161615-A1 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | DOOSAN CORPORATION (KR) | 2012-06-28 | — | — | US | disclosed |
| US-20120161615-A1 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | DOOSAN CORPORATION (KR) | 2012-06-28 | — | — | US | disclosed |
| WO-2010147318-A2 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | 주식회사 두산 (KR) | 2010-12-23 | — | — | WO | disclosed |
| WO-2010147318-A2 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | 주식회사 두산 (KR) | 2010-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161615-A1 | AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | AADAT, ALAD, AAAS | PDK2 1566/4885CYP2A6 2591/4885ALDH1A1 277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.